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A B S T R A C T   
Background: Recent evidence suggests that high-speed, low-resistance stationary cycling training (termed as 
speedwork) alleviates motor symptoms in people with Parkinson’s disease. Similar motor symptoms commonly 
exist in people with schizophrenia (Sz); however, they were neglected in the previous literature. 
Objectives: Our objective was to evaluate if speedwork could also be used as a strategy to improve parkinsonian 
motor symptoms in Sz. We aimed 1) to evaluate the adherence and acceptability of speedwork in Sz, 2) to assess 
test-retest reliability of the motor assessments that are novel to Sz research, 3) to evaluate the effectiveness of 
speedwork in improving parkinsonian motor, and 4) psychiatric symptoms in Sz. 
Methods: Ten Sz outpatients with concurrent parkinsonian motor symptoms completed 12 sessions (2 sessions/ 
week) of speedwork training. Participants were evaluated on motor functioning and psychiatric symptom 
severity twice before (double baseline) and twice after (post-completion and 6-wk follow-up) the speedwork 
training. 
Results: The adherence to speedwork was high (92 %) and the results of exercise acceptability questionnaire 
indicate participants found various domains of exercise highly acceptable (overall average 4.49/5). There were 
improvements in various domains of motor symptoms including, walking speed, functional mobility, static and 
dynamic balance, and upper extremity motor function after the completion of training (all p < 0.025), with many 
of these improvements remaining at the 6-wk follow-up. Moreover, there was evidence for improvement in 
positive psychotic symptoms after the completion of speedwork (p < 0.025). 
Conclusions: Speedwork training could be an acceptable and effective strategy to improve motor and psychiatric 
symptoms in Sz.   
1. Introduction 
Parkinsonian motor symptoms including bradykinesia (slowness in 
movement speed), rigidity, poor balance, and diminished postural 
control are found in up to one third of those diagnosed with schizo-
phrenia (Sz).1–5 While the use of first-generation antipsychotic medi-
cations can induce (or exacerbate) these motor symptoms,6 elevated 
parkinsonism commonly seen in Sz who are naïve to antipsychotic 
medications7,8 indicate that these movement issues are a unique part of 
the pathophysiology in Sz, associated with dysfunction in basal 
ganglia-cortical mechanisms.9,10 The presence of these symptoms in this 
population hamper the activities of daily living,11 further contribute to 
inactivity,12 and represent a public health concern due an increased risk 
of fall-related injuries and fatalities.13,14 In addition, the medications 
used to treat parkinsonian motor symptoms (i.e., anticholinergics) are 
not recommended for long-term use due to their own undesirable 
side-effects (e.g., cognitive impairment, blurred vision, tachy-
cardia).15,16 Therefore, there is a strong need to develop non-medical 
strategies that can be utilized concurrently with existing treatments to 
improve overall motor function in Sz. 
Fortunately, it may be possible to translate successful strategies for 
improving motor functioning in individuals with Parkinson’s disease 
towards reducing parkinsonian motor symptoms commonly seen in 
schizophrenia. Evidence from our lab suggests engagement in a series of 
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specialized cycling exercises significantly improved motor functioning 
in patients with Parkinson disease without the negative side effects 
associated with medication-based treatments.17,18 This novel 
high-speed, low-intensity intermittent cycling program (termed speed-
work) involves a progression of pedaling intervals on a recumbent sta-
tionary bike that alternate from slow to high speeds during 30-minute 
sessions that occur 2x per week over a 6-week period. Speedwork 
training is a unique one since 1) it elicits high rates of neural stimulation 
without exposure to high levels of muscular forces that can be unap-
pealing to some individuals, 2) it reduces the risk of injuries (e.g., falls) 
compared with existing training modalities that use treadmills or up-
right bikes, and 3) it can be administered in home or clinical settings 
with minimal space requirements. While the previous literature docu-
mented that moderate to high intensity aerobic exercise could decrease 
the severity of both positive and negative symptoms, improve cognitive 
functioning, and cardiovascular fitness in Sz,19–22 at present there is no 
research on the potential benefits of a targeted exercise intervention on 
parkinsonian motor symptoms in Sz. Thus, we believe that our novel 
speedwork training that was proven to be effective with Parkinson’s 
disease can be successfully adapted for those diagnosed with Sz with 
potential benefits across a range of clinical domains. 
In the current pilot study, we aimed to evaluate acceptability and 
effectiveness of the speedwork program in people with Sz who display 
parkinsonism (defined as “5” or above on the motor section of the 
Unified Parkinson’s Disease Rating Scale -UPDRS-III).23,24 Our specific 
aims were to 1) assess the adherence (i.e. attendance rates) and 
acceptability of the speedwork training, 2) evaluate the test-retest reli-
ability of the standard assessments of motor function that are mainly 
novel to Sz research, 3-) document the effectiveness of the speedwork 
training program in improving the parkinsonian motor and 4-) psychi-
atric symptoms in Sz. We hypothesized that the speedwork training 
would be an effective strategy to improve parkinsonian motor and 
psychiatric symptoms in people with Sz. 
2. Methods 
This study used a single group repeated measures design with four 
assessment sessions, including double-baseline, post-intervention, and 
retention. The study was conducted between April 2019 and April 2020. 
The study methodology was approved by the university IRB 
(Pro2018000292; FWA00007111) as well as an ethics/privacy com-
mittee at the community mental health agency where recruitment/data 
collection occurred. 
Recruitment occurred in a two-step process involving (1) a referral of 
a possible participant from a knowledgeable clinician, and (2) a verifi-
cation of eligibility through assessment of inclusion criteria (described 
below). Only individuals who indicated an interest in ‘learning more’ 
about our study in a conversation with their clinician were approached 
by our team. Inclusion criteria included (a) a diagnosis of Sz or schizo-
affective disorder by a board-certified psychiatrist, Recruitment 
occurred in a two-step process involving (1) a referral of a possible 
participant from a knowledgeable clinician, and (2) a verification of 
eligibility through assessment of inclusion criteria (described below). 
Only individuals who indicated an interest in ‘learning more’ about our 
study in a conversation with their clinician were approached by our 
team. Inclusion criteria included (a) a diagnosis of Sz or schizoaffective 
disorder by a board-certified psychiatrist.25 The UPDRS is a clinical 
rating tool that qualitatively evaluates the severity of Parkinson’s dis-
ease. UPDRS-III is a subsection of UPDRS that is used to evaluate motor 
symptoms of the patients and it can range between 0 and 132 (higher 
scores indicate increased severity). In the absence of a definitive cut off 
for this population, we selected a score of 5 based on outpatient averages 
for the measure in the literature.23,24 We simply needed a way to include 
people diagnosed with schizophrenia that had “higher than average” 
motor symptoms. So, this was decided as the minimum “floor” for in-
clusion. Exclusion criteria included (a) being unable to understand 
spoken instructions or communicate with the investigators; (b) having 
resting heart rate either less than 40 or higher than 100 beats/min or 
resting blood pressure either lower than 90/60 or higher than 140/90; 
and (c) being not ambulatory without the assistance of another person or 
a cane or walker. Potential participants were provided detailed infor-
mation about the study and voluntarily provided informed consent prior 
to the collection of any data. Prior to initiating the exercise portion of the 
study, we administered Physical Activity Readiness Questionnaire and 
“risk stratification” items from the American College of Sports Medicine. 
Any endorsement of these items required a written clearance from a 
physician before participation in the training program. 
A total of 14 participants were referred to the study by their clinical 
provider and subsequently approached by our research team. One 
participant declined involvement, citing ambivalence about the time 
commitment. The remaining 13 participants were verified as eligible 
and accepted into the study. Of these 13 participants, 2 dropped out 
before the beginning of the training sessions (one indicated they were no 
longer interested and one indicated that their psychiatric symptoms 
disabled participation) and 1 left the agency after participating at the 
sixth training session. Thus 10 participants fully completed the study. 
The demographic and clinical information of both completers and 
dropouts are shown in Table 1. 
2.1. Study intervention: speedwork on a stationary recumbent bicycle 
Speedwork training sessions included high-speed, low-resistance 
cycling using a stationary recumbent bicycle (Model: Nautilus R616, 
Nautilus Corp, Vancouver, Wash) under the supervision of an experi-
enced trainer. Participants completed 12 speedwork sessions in 6 weeks 
(2 sessions/week), each session lasting 30 min. The speedwork sessions 
were separated by at least 48 h and the time of day was kept the same 
across the training period of each individual. Throughout the training 
sessions, the resistance of the bike was set at the lowest possible setting 
so that the power produced by the participants did not exceed 100 W 
even at their highest pedaling rate. In the first and last five minutes of 
each session, participants were asked to pedal at a preferred comfortable 
cadence to warm-up and cool down, respectively. After warm-up, par-
ticipants were asked to pedal as fast as possible (which varied based on 
participant and their comfort level) for the first 20 s of every minute for 
20 min. Trainers monitored the heart rate of the participants and pro-
vided longer recovery periods between the high-speed bouts when heart 
rate reached 80 % of the maximum heart rate (maximum heart rate was 
calculated as 220-age). 
2.2. Assessments sessions 
There were four assessment sessions in this study, including double 
Table 1 
Baseline demographic and clinical information.  
Descriptive (mean (SD)) Completers (n = 10) Dropouts (n = 3) 




Age (years) 45.4 (14.0) 44.0 (13.1) 
Weight (kg) 90.6 (19.9) 81.7 (25.7) 
Height (cm) 166.1 (11.1) 173.9 (12.6) 
Education (years) 11.89 (2.09) 13.50 (2.17) 
Smokers; # of cigarettes 3; 6 (2) 0; 0 
Systolic blood pressure (mmHg) 112.1 (7.9) 130.0 (18.36) 
Diastolic blood pressure (mmHg) 75.0 (10.9) 86.67 (7.51) 
Resting heart rate (beats/min) 73.6 (28.5) 64.33 (5.51) 
UPDRS-III1 18.90 (12.56) 20.33 (15.69) 
Antipsychotics (CPZ2 Equiv.; mg/day) 604.4 (288.7) 441.67 (52.04)  
1 UPDRS-III, Unified Parkinson’s Disease Rating Scale Motor Function 
Assessment. 
2 CPZ = Chlorpromazine. 
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baseline pre-speedwork training (T1 and T2), post-speedwork training 
(T3), and 6-week after the completion of speedwork training (i.e. follow- 
up; T4). To control for the initial practice/learning effects and to eval-
uate the test-retest reliability of the motor assessments that are mainly 
novel to schizophrenia research, we conducted T1 and T2 before the 
speedwork training that were separated by at least two and at most 
seven days. While baseline motor assessments were completed in both 
T1 and T2, psychiatric assessments were performed only in T1 since 
there was no need to control for practice effects and the outpatients were 
relatively stable in their symptoms as a precondition of eligibility. All 
assessments were completed by participants within 1-wk of completing 
the speedwork training (T3) and at a 6-wk follow-up (T4). 
2.3. Adherence and acceptability assessments 
Adherence was measured by % attendance to the training sessions. 
To assess the acceptability of speedwork training, the authors created a 
26-item exercise acceptability questionnaire to examine participants’ ex-
periences with the exercise intervention. Items were rated from 1 
(strongly disagree) to 5 (strongly agree) and each item was worded so 
that higher ratings indicated a better experience. Responses were 
grouped into nine categories involving 1) ease of use, 2) enjoyment of 
exercise, 3) comfort, 4) ability to use bike without assistance, 5) inten-
tion to use bike if available where they live, 6) perception of improved 
physical fitness, 7) the manageability of the exercise schedule, 8) 
enjoyment of the social elements of the intervention, and 9) belief that 
exercise should be incorporated into mental health care. Cronbach’s 
Alpha for the 26-items was high (α = .89) indicating strong internal 
reliability. Participants completed the questionnaire in their T3 assess-
ment session. 
2.4. Motor assessments 
In each assessment session and before each test, participants were 
given practice trials until they felt comfortable performing the task. 
After practice trials, each test of motor function was performed three 
times and 30-s rest time was provided between trials. Participants were 
instructed to perform the timed tests “as fast and as safe as possible”. 
Two experienced researchers timed the tests and their average value was 
recorded for each trial. The average values of the three trials were used 
in further analysis. The order of the tests of motor function was ran-
domized in each assessment session. 
Similar to our research in Parkinson’s disease,17,18 we used standard 
tests to evaluate the various domains of parkinsonian motor symptoms 
in Sz. Ten-meter walk test (10 mW) is a walking test that measures the 
time and number of steps (Steps) that individuals take to walk the middle 
6 m of the 10 m walk. Timed-up-and-go test (TUG) is a test of functional 
mobility, during which the time it takes to stand up from a chair, walk 3 
m, turn, walk back to the chair, and sit down is measured. Functional 
reach test (FRT) is a static balance test that measures the maximum 
distance that one can reach in the forward direction while maintaining 
the base of support fixed. Four square step test (4SST) is a dynamic bal-
ance test during which participants are required to rapidly change di-
rection in the forward, backward, and sideways directions while 
stepping over a low obstacle. The Nine-hole peg test (9-HPT) is a test of 
upper extremity function that measures the time it takes an individual to 
place nine pegs into nine holes in a peg board and thereafter to remove 
them one at a time. In 9-HPT both dominant and nondominant hands 
were assessed separately. 
2.5. Psychiatric assessments 
Chart diagnosis of Sz or related disorder was verified through the 
information contained in the participants’ medical records and infor-
mation collected during the eligibility meeting (via Structured Clinical 
Interview for the DSM-5; SCID). Information collected during the 
eligibility meeting provided us the information needed to rate the 
severity of current psychiatric symptoms using the Brief Psychiatric 
Rating Scale-Expanded (BPRS-E)25,26 which contains detailed anchor 
points and probe questions. This measure has 24 symptom items that are 
rated on a 7-point scale from 1 (not present) to 7 (extremely severe). 
Research supports the BPRS-E as a sensitive measure of psychiatric 
symptoms with good interrater reliability over time.26,27 The four 
symptom groupings examined in the present study (Positive, Negative, 
Affect, and Activation symptoms) are based on the core symptoms 
identified in several recent comprehensive studies.28,29 Positive symp-
toms included items of Suspiciousness, Hallucinations, and Unusual 
Thought Content; Negative symptoms included items of Blunted Affect, 
Emotional Withdrawal, and Motor Retardation; Activation symptoms 
included items of Elevated Mood, Excitement, and Motor Hyperactivity; 
Affect symptoms included items of Depression, Suicidality, and Guilt. 
The Positive and Negative Affect Scale (PANAS)30 is comprised of 20 
adjectives describing 10 positive and 10 negative affective states (e.g., 
“enthusiastic”, “upset”) that participants are asked to rate on a scale 
from 1 (very slightly or not at all) to 5 (extremely). The scales have internal 
consistencies of 0.89 and 0.85 for positive affect and negative affect, 
respectively.31 
2.6. Statistical analysis 
Data analyses were conducted using IBM SPSS ver. 26. Means and 
standard deviations were used to report all dependent variables. The 
relative and absolute test-retest reliability of the tests of motor symp-
toms were quantified using intraclass correlation coefficient (ICC3,1) 
and coefficient of variation (CV = 100*standard deviation/mean), 
respectively. ICC values between 0.5–0.75 suggests moderate, 0.75–0.9 
suggests good, and ICC > 0.9 suggests excellent relative reliability,32 
while CV < 15 % is considered good absolute reliability.33 
Paired sample t-tests revealed no significant differences in any of the 
motor assessments between the baseline sessions (T1 and T2) and, 
therefore, we collapsed them into a single baseline measurement by 
taking their average values (T1–2). We ran Kolmogorov-Smirnov tests 
for the normality tests for each variable. Due to the frequent violation of 
the normality assumption mainly observed in the psychiatric assess-
ments, we adopted the nonparametric equivalent of a one-sample 
repeated measures ANOVA (i.e., the Friedman Test) to compare the 
studied variables among the testing sessions. We ran the post-hoc 
comparisons using Wilcoxon-Signed test. We applied Bonferroni 
adjustment when comparing the assessments in post-speedwork training 
(T3 vs T1–2) and 6-wk follow-up (T4 vs T1–2) with respect to baseline 
and, therefore, the significance level was set at 0.025 (0.05/2). 
3. Results 
3.1. Adherence and acceptability of speedwork 
Among the total of 120 exercise sessions (10 participants * 12 ses-
sions), there was no unexcused absence and only 8 excused absences. 
Scores (mean (standard deviation)) on the nine experience/belief cate-
gories derived from the Exercise Acceptability Questionnaire were as 
follows: ease of use = 4.60 (0.53), enjoyment of exercise = 4.60 (0.68), 
lack of discomfort = 4.38 (0.62), ability to use bike without assistance =
4.60 (0.63), intention to use bike if available where they live = 4.49 
(.98), perception of improved physical fitness = 4.20 (0.61), the man-
ageability of the exercise schedule = 4.70 (0.5), enjoyment of the social 
elements of the intervention = 4.22 (0.90), and belief that exercise 
should be incorporated into mental health care = 4.61 (0.79). 
The average fast (SD) and average preferred (SD) pedaling cadence 
was 120.2 (38.5) rpm and 54.8 (11.1) rpm, respectively. Results indicate 
that the average fast pedaling rate of two participants was considerably 
lower (54 and 66 rpms) than the other eight participants (ranged be-
tween 100 and 176 rpm). However, correlations between average fast- 
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pedaling cadences and motor symptom change scores did not yield any 
meaningful relationship leading the authors to conclude that positive 
outcomes related to ‘speedwork’ may be possible if participants are 
pedaling at their fastest capacities. All participants completed the 
training with no adverse effects. 
3.2. Reliability of motor assessments 
The reliability statistics for the motor assessments are presented in 
Table 2. The between session reliability of all the studied motor as-
sessments showed moderate to excellent relative (ICCs ranged between 
0.58 and 0.95) and good absolute (CV% ranged between 4.85 and 13.04) 
test-retest reliability. 
3.3. Motor assessments 
Table 3 displays the statistics of motor and psychiatric assessments 
completed before and after the completion of 6-week (12 sessions) 
speedwork training. Most of the tests of motor function improved with 
the completion of 6-week speedwork training (p < 0.025) and this 
improvement was persistent after a 6-week follow-up period (p <
0.025). The only exception was the 9-HPT of both dominant and 
nondominant limbs, whose performances were improved after the 
completion of speedwork but not after 6-wk follow-up (p > 0.025). 
3.4. Psychiatric assessments 
Mean symptom severity (BPRS-E) and positive/negative affect 
(PANAS) ratings at three time points are provided in Table 3. Notably, 
there was a significant change (reduction) in positive symptoms and 
total BPRS after the completion of 6-week speedwork training (p =
0.021) and those improvements in total BPRS were observed after a 6- 
week follow-up period (p = 0.017) (Table 3). Post-hoc analyses sug-
gested that the specific symptom contributing most to this finding was 
Suspiciousness with a reduction from baseline (T1 = 2.7 (1.64)) at both 
follow time points (T3 = 1.4 (0.97); p = 0.026 & T4 = 1.4 (0.70); p =
0.026). 
4. Discussion 
This pilot study was designed to evaluate the acceptability and 
effectiveness of a high speed, low resistance cycling training program (i. 
e., speedwork) aiming to improve parkinsonian motor and psychiatric 
symptoms in Sz. Results indicated speedwork training as an acceptable 
form of exercise in Sz with high adherence rates. We found that the 
completion of 6-week (12 sessions) of speedwork training was associ-
ated with improvement in various domains of motor functioning, 
including walking speed, functional mobility, static and dynamic bal-
ance, and upper extremity function. In addition, there was also evidence 
for reduced severity in positive psychotic symptoms. 
4.1. Adherence and acceptability of speedwork 
The speedwork training was well tolerated. Most individuals re-
ported that engaging in this form of physical activity was enjoyable and 
they felt the level of difficulty and amount of time required was 
manageable. Most individuals reported that they believed the exercise 
was related to improved functioning (e.g., walking speed, stability) and 
physical fitness. They positively endorsed the notion of incorporating 
physical activity into their mental health care indicated that they would 
be able and willing to use the recumbent bike at their residence if a bike 
was available. However, these elements of the questionnaire were “hy-
pothetical”, thus additional research is necessary to determine if in-
dividuals would utilize this form of exercise equipment in natural living 
conditions (e.g., outside of an externally imposed exercise schedule, 
facilitated by others, etc.). 
The adherence rate to the speedwork (~92 %) was higher than those 
reported in other exercise intervention studies (78.8 %),22 which could 
be due the incentives provided to participants (~$20 for each exercise 
session),34 intermittent nature of the speedwork training that promotes 
more involvement,12 and the presence of the supervision during 
sessions.22 
4.2. Reliability of the motor assessments 
All tests of motor function had acceptable test-retest reliability, 
which indicates that the improvements observed in motor assessments 
after the completion of speedwork is not simply a “learning effect”. 
Moreover, this finding suggests that future research could use the as-
sessments of motor function used in this study to objectively evaluate 
the various domains of motor functioning and quantify the effectiveness 
of medical and nonmedical interventions in Sz. 
4.3. Motor assessments 
Our results indicate that all the studied domains of motor function 
improved significantly after the completion of only 6-wk speedwork 
training. While targeting parkinsonian motor symptoms via an exercise 
routine is novel in Sz, improvements in some of the motor functions 
could be expected considering the anatomically common elements be-
tween the high-speed cycling and some of the motor tests (10 mW, TUG, 
and 4SST). The untrivial findings are that the improvements observed in 
static balance (as assessed by FRT) and upper extremity function (as 
assessed by 9-HPT) after the completion of a lower extremity exercise 
program, which might indicate the presence of higher-level neural ad-
aptations following speedwork. 
These findings are similar to previous research in people with Par-
kinson’s disease after the completion of high-speed passive35 and 
active17 stationary cycling. To our knowledge, this is the first study to 
directly examine the benefits of a non-medical intervention to improve 
motor functioning in people diagnosed with schizophrenia-spectrum 
disorders. We speculate that the improvements observed in different 
domains of parkinsonian motor symptoms in Sz after the completion of 
speedwork could be due to the exercise-related neural adaptations 
associated with neurotrophic proteins36,37 and improvements in the 
dopamine receptor activity within the basal ganglia.38 Future research is 
warranted to further explore the speedwork related possible adaptations 
within the central nervous system. 
4.4. Psychiatric assessment 
Participants reported a reduction in positive symptoms, primarily 
suspiciousness. Our findings are consistent with findings of the seminal 
review conducted by Firth et al. where the effect of exercise was greater 
in reducing positive psychotic symptoms than negative symptoms.22 
Contrary to expectations, participants in the current study did not report 
significant improvement in negative psychotic symptoms, mood related 
Table 2 
Relative (intraclass correlation coefficient; ICC) and absolute (coefficient of 
variation; CV) test-retest reliability values of the motor assessments.   
ICC (3,1) (95 % CI) CV% 
10 mW (s) 0.95 (0.80–0.99) 7.74 
Steps (#) 0.88 (0.60–0.97) 5.14 
TUG (s) 0.88 (0.58–0.97) 8.03 
FRT (m) 0.58 (− 0.03–0.88) 13.04 
4SST (s) 0.72 (0.20–0.92) 13.36 
9HPT_Dom (s) 0.88 (0.60–0.97) 5.35 
9HPT_Ndom (s) 0.91 (0.68–0.98) 4.85 
10 mW: 10-meter Walk Test; Steps: number of steps taken in 10 mW; TUG: 
Timed-Up-and-Go; FRT: Functional Reach Test; 4SST: Four-Square Step Test; 9- 
HPT_dom: Nine-hole Peg Test dominant hand; 9-HPT_nondom: Nine-hole Peg 
Test non dominant hand. 
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symptoms (e.g., depression), or positive or negative affect. However, the 
current intervention was relatively short in duration both within each 
session and across time. We would conjecture that if the duration of the 
intervention was expanded to 90 min/week (i.e., three speedwork ses-
sions/week), which was recommended by Firth et al. (2015)22 to 
maximize the benefits of moderate to vigorous exercise, additional 
benefits would likely emerge. 
4.5. Limitations 
Limitations of this pilot study include a small sample size, the lack of 
a control group, the implementation of the intervention in a structured 
setting, and the use of incentives, thus limiting the generalizability of 
findings. Moreover, one can argue that the improvements observed after 
speedwork training could be due to social aspects of the training pro-
gram rather than the exercise itself. Therefore, the findings of this study 
should be viewed as tentative pending additional research. Future 
research should use well-defined experimental conditions to further 
evaluate acceptability and effectiveness across different settings and 
comparison groups. For example, research comparing the effectiveness 
of speedwork conducted at the individual’s home (vs. in a supervised 
social setting), or compared to a non-exercise control group receiving 
comparable social interaction and incentives, will help establish what 
effects can be attributed directly to the speedwork activities. 
5. Conclusion 
In conclusion, speedwork training is a highly acceptable training 
modality in individuals with Sz. Moreover, the brevity, ease of admin-
istration, space requirements, and safety of the training suggest that 
speedwork could be realistically integrated with the current standard 
care, minimally affecting the treatment routine. Keeping limitations in 
mind, the findings of this small pilot study indicate that reductions of 
motor and psychiatric symptoms may be possible by adding speedwork 
training to the existing care strategies for Sz. However, adequately 
powered future randomized controlled studies with well-defined 
experimental and comparison conditions are needed to validate our 
findings. 
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